407623-72-7 Usage
Uses
Used in Pharmaceutical Industry:
(3-Hydroxymethyl-pyridin-4-yl)-carbamic acid tert-butyl ester is used as a reagent for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its versatility in reacting with different functional groups allows for the creation of a wide range of medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, (3-Hydroxymethyl-pyridin-4-yl)-carbamic acid tert-butyl ester is employed as a reagent in the production of agrochemicals, such as pesticides and herbicides. Its ability to form complex organic molecules aids in the development of effective and targeted agricultural products.
Used as a Protective Group in Peptide Chemistry:
(3-Hydroxymethyl-pyridin-4-yl)-carbamic acid tert-butyl ester serves as a protective group in peptide chemistry, ensuring the selective protection of functional groups during the synthesis of peptides. This role is crucial for the successful assembly of peptide sequences and the prevention of unwanted side reactions.
Used as a Precursor for Carbamate Derivatives:
(3-HYDROXYMETHYL-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER also acts as a precursor for the synthesis of carbamate derivatives, which have various applications in different fields, including pharmaceuticals, agrochemicals, and materials science. The synthesis of carbamates from (3-Hydroxymethyl-pyridin-4-yl)-carbamic acid tert-butyl ester expands the range of accessible chemical structures and functionalities.
Check Digit Verification of cas no
The CAS Registry Mumber 407623-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,6,2 and 3 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 407623-72:
(8*4)+(7*0)+(6*7)+(5*6)+(4*2)+(3*3)+(2*7)+(1*2)=137
137 % 10 = 7
So 407623-72-7 is a valid CAS Registry Number.
407623-72-7Relevant academic research and scientific papers
USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING
-
Paragraph 00196, (2013/12/03)
The present disclosure provides novel compounds, including compounds that bind to potassium channels, methods for their manufacture, and methods for their use, including for the treatment of demyelinating diseases and/or in vivo imaging of the central nervous system to diagnose and/or assess the progression of MS or other diseases.
